Cardiac troponin I as diagnostic and prognostic marker in severe heart failure.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  The Journal of Heart and Lung Transplantation

• Publication date

  2000-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S1053-2498(00)00120-0PMID 10930813
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Functional assessment with electrocardiographic gated single-photon emission computed tomography improves the ability of technetium-99m sestamibi myocardial perfusion imaging to predict myocardial viability in patients undergoing revascularization.

  1999cited by this paper
• Consensus recommendations for the management of chronic heart failure: Introduction

  1999cited by this paper
• Ischemia and left ventricular dysfunction

  1998cited by this paper
• Ischemia and left ventricular dysfunction: a reciprocal relation?

  1998cited by this paper
• Programmed cell death in the progression of heart failure.

  1998cited by this paper
• Epidemiological burden of heart failure

  1998cited by this paper
• Cardiac troponin T in patients with clinically suspected myocarditis.

  1997cited by this paper
• Circulating cardiac troponin I in severe congestive heart failure.

  1997cited by this paper
• Apoptosis in the failing human heart.

  1997cited by this paper
• Detectable serum troponin I in patients with heart failure of nonmyocardial ischemic origin.

  1997cited by this paper
• The epidemiology of heart failure.

  1997cited by this paper
• Coronary circulation in the failing heart.

  1997cited by this paper
• Predicting outcomes in severe heart failure.

  1997cited by this paper
• Textbook of Cardiovascular Medicine

  1997cited by this paper
• Apoptosis in myocytes in end-stage heart failure.

  1996cited by this paper
• Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation.

  1996cited by this paper
• Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes.

  1996cited by this paper
• Structural remodeling and mechanical dysfunction of cardiac myocytes in heart failure.

  1995cited by this paper
• Pathophysiologic aspects of end-stage heart failure.

  1995cited by this paper
• Normal and abnormal consequences of apoptosis in the human heart. From postnatal morphogenesis to paroxysmal arrhythmias.

  1994cited by this paper
• Normal and abnormal consequences of apoptosis in the human heart: from postnatal morphogenesis to paroxysmal arrhythmias.

  1994cited by this paper
• Elevated donor cardiac troponin I. A marker of acute graft failure in infant heart recipients.

  1994cited by this paper
• Cardiac troponin T and CK-MB mass release after visually successful percutaneous transluminal coronary angioplasty in stable angina pectoris.

  1994cited by this paper
• Survival After the Onset of Congestive Heart Failure in Framingham Heart Study Subjects

  1993cited by this paper
• Cardiac Troponin I A Marker With High Specificity for Cardiac Injury

  1993cited by this paper
• Ventricular remodeling after myocardial infarction.

  1993cited by this paper
• ANG II receptors, c-myc, and c-jun in myocytes after myocardial infarction and ventricular failure.

  1993cited by this paper
• Predictors of prognosis in patients awaiting heart transplantation.

  1993cited by this paper
• Coronary flow reserve in patients with dilated cardiomyopathy.

  1993cited by this paper
• Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life.

  1993cited by this paper
• Remodeling and reparation of the cardiovascular system.

  1992cited by this paper
• S-troponin T in suspected ischemic myocardial injury compared with mass and catalytic concentrations of S-creatine kinase isoenzyme MB.

  1991cited by this paper
• Release of creatine kinase-MB and cardiac specific troponin-I following percutaneous transluminal coronary angioplasty.

  1991cited by this paper
• Increased concentrations of tumour necrosis factor in "cachectic" patients with severe chronic heart failure.

  1991cited by this paper
• Pathological Hypertrophy and Cardiac Interstitium: Fibrosis and Renin‐Angiotensin‐Aldosterone System

  1991cited by this paper
• Ventricular Remodeling After Myocardial Infarction: Experimental Observations and Clinical Implications

  1990cited by this paper
• Abnormalities of diastolic function as a potential cause of exercise intolerance in chronic heart failure.

  1990cited by this paper
• Elevated circulating levels of tumor necrosis factor in severe chronic heart failure.

  1990cited by this paper
• Cardiac troponin T in developing, regenerating and denervated rat skeletal muscle.

  1990cited by this paper
• Cardiac-specific troponin-I radioimmunoassay in the diagnosis of acute myocardial infarction.

  1987cited by this paper
• Clinical determinants of mortality in chronic congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy.

  1987cited by this paper
• Myocarditis. A histopathologic definition and classification.

  1987cited by this paper
• Left ventricular mechanics in dilated cardiomyopathy.

  1984cited by this paper
• Comparative Reproducibility and Validity of Systems for Assessing Cardiovascular Functional Class: Advantages of a New Specific Activity Scale

  1981cited by this paper

• Advances in Therapeutic Targets and Traditional Chinese Medicine for Cardiomyopathy

  2025cites this paper
• Potential Cardioprotective Effect of a GRK5 Inhibitor Against NF-κB-Mediated Inflammation in an Animal Model of Isoproterenol-Induced Myocardial Infarction

  2025cites this paper
• Implementation of Cardiac Troponin I as A Sensitive Biomarker for Myocardial Injury in Animals: Review Article

  2024cites this paper
• Novel Biomarkers in Early Detection of Heart Failure: A Narrative Review

  2024cites this paper
• Clinical Interpretation of Serum Troponin in the Era of High-Sensitivity Testing

  2024cites this paper
• A Case-based Analytical Review on How to Evaluate Elevated Troponin Levels in Patients Excluding Myocardial Infarction

  2023cites this paper
• Interpretation of Cardiac and Non-Cardiac Causes of Elevated Troponin T Levels in Non-Acute Coronary Syndrome Patients in the Emergency Department

  2022cites this paper
• Relationship Between Preprocedural Lipid Levels and Periprocedural Myocardial Injury in Patients Undergoing Elective Percutaneous Coronary Intervention.

  2022cites this paper
• Electrochemical Impedance Spectroscopy (EIS): Principles, Construction, and Biosensing Applications

  2021cites this paper
• Biomarkers in the clinical management of patients with atrial fibrillation and heart failure

  2021cites this paper
• Canine Traditional Laboratory Tests and Cardiac Biomarkers

  2020cites this paper
• Elevated Troponin- Is it Time to Consult A Cardiologist? A Case Series with Review of the Literature

  2020cites this paper
• Benefits of Home-Based Solutions for Diagnosis and Treatment of Acute Coronary Syndromes on Health Care Costs: A Systematic Review

  2020cites this paper
• Top-down proteomics: challenges, innovations, and applications in basic and clinical research

  2020cites this paper
• An emergency medicine approach to troponin elevation due to causes other than occlusion myocardial infarction.

  2019cites this paper
• The Role of Troponin for Acute Heart Failure

  2019cites this paper
• High-Sensitive Troponin I and Re-Hospitalization in Patients With Decompensated Congestive Heart Failure

  2019cites this paper
• Is Cardiac Troponin I Valuable to Detect Low-Level Myocardial Damage in Congestive Heart Failure?

  2019influential citation
• Predictive factors for longer length of hospital stay in patients with heart failure

  2019cites this paper
• Biomarkers in heart failure: the past, current and future

  2019cites this paper
• A Review of Cardiac and Non Cardiac Causes of Troponin Elevation and Clinical Relevance Part II Non Cardiac Causes

  2018cites this paper
• A Review of Cardiac and Non-Cardiac Causes of Troponin Elevation and Clinical Relevance Part II: Non Cardiac Causes

  2018cites this paper
• Predictors of cardiovascular outcome and rehospitalization in elderly patients with heart failure

  2018cites this paper
• Rates of Echocardiography, Coronary Angiography, and Coronary Intervention Associated With Troponin Testing in Hospitalized Patients.

  2018cites this paper
• The prognostic value of high sensitive cardiac troponin I in patients receiving cardiac resynchronisation therapy

  2018cites this paper
• Novel Biomarkers of Heart Failure.

  2017cites this paper
• Troponin through the looking-glass: emerging roles beyond regulation of striated muscle contraction

  2017cites this paper
• Natriuretic Peptides as Biomarkers for Congestive States: The Cardiorenal Divergence

  2017cites this paper
• Acute Heart Failure Syndromes

  2017cites this paper
• Creating a Biomarker Panel for Early Detection of Chemotherapy Related Cardiac Dysfunction in Breast Cancer Patients.

  2017cites this paper
• Biomarkers in emergency cardiology : cardiopulmonary resuscitation , acute coronary syndromes , pulmonary thromboembolism , acute aortic syndrome and acute heart failure

  2017cites this paper
• Cardiac troponin T as a predictor of cardiac death in patients with left ventricular dysfunction

  2017cites this paper
• Serelaxin in the Treatment of Acute Heart Failure in the Emergency Department

  2017cites this paper
• An association between volumes of the cardiac chambers and troponin levels in individuals submitted to cardiac coronary computed tomography

  2017cites this paper
• Predictors of Post-discharge Mortality Among Patients Hospitalized for Acute Heart Failure.

  2017cites this paper
• Correlation between cardiac troponin I and dilated cardiomyopathy and mechanism analysis

  2017cites this paper
• Cardiac troponin in patients hospitalized with acute decompensated heart failure: A systematic review and meta-analysis.

  2016cites this paper
• Inflammatory and Cardiac Biomarkers are Differentially Expressed in Chagas Disease

  2016cites this paper
• Pathophysiology of Heart Failure and an Overview of Therapies

  2016cites this paper
• Treatment Does Not Decrease Lipid Peroxidation In Decompansated Heart Failure

  2016cites this paper
• Chapter 34 – Cardiac Blood Tests

  2016cites this paper
• N-terminal pro-brain natriuretic peptide and cardiac troponin I for the prognostic utility in elderly patients with severe sepsis or septic shock in intensive care unit: A retrospective study.

  2015cites this paper
• Role of Cardiac Troponin Levels in Acute Heart Failure.

  2015cites this paper
• CARDIAC BIOMARKERS: PAST, PRESENT AND FUTURE

  2015cites this paper
• Clinical Profile of Cardiac Failure and Its Correlation with Lab Markers and Outcome

  2015cites this paper
• The application of cardiac biomarkers as detectors for cardiac disease in horses

  2015cites this paper
• Sveriges lantbruksuniversitet Fakulteten för Veterinärmedicin och husdjursvetenskap Institutionen för Kliniska Vetenskaper Klinisk användning av Troponin I hos hund och katt

  2015cites this paper
• Inflammatory and cardiac biomarkers are differentially expressed in clinical stages of Chagas disease.

  2015cites this paper
• Biomarkers in Acute Decompensated Heart Failure

  2015cites this paper
• State of the Art: Newer biomarkers in heart failure

  2015cites this paper
• Mouse models of autoimmune diseases - autoimmune myocarditis.

  2015cites this paper
• Cardiac biomarkers in heart failure.

  2014cites this paper
• Diagnosis and therapeutic management of myocardial and valvular diseases in dogs

  2014cites this paper
• Serial analysis of serum cardiac troponin I changes and correlation with clinical findings in 46 dogs with mitral valve disease.

  2014cites this paper
• The prognostic use of serum concentrations of cardiac troponin-I, CK-MB and myoglobin in patients with idiopathic dilated cardiomyopathy.

  2014cites this paper
• Serelaxin: A Novel Therapy for Acute Heart Failure with a Range of Hemodynamic and Non-Hemodynamic Actions

  2014cites this paper
• Cationic isotachophoresis separation of the biomarker cardiac troponin I from a high‐abundance contaminant, serum albumin

  2014cites this paper
• Biomarkers in Cardiology – Part 1 – In Heart Failure and Specific Cardiomyopathies

  2014cites this paper
• Prognostic value of the physical examination in patients with heart failure and atrial fibrillation: insights from the AF-CHF trial (atrial fibrillation and chronic heart failure).

  2014cites this paper
• Cardiac Biomarkers in Acute Coronary Syndromes

  2013cites this paper
• Heart Failure Biomarkers

  2013cites this paper
• Evaluating Chagas disease progression and cure through blood-derived biomarkers: a systematic review

  2013cites this paper
• Cardiac troponin-I concentration, myocardial arteriosclerosis, and fibrosis in dogs with congestive heart failure because of myxomatous mitral valve disease.

  2013cites this paper
• Biomarkers of Pulmonary Hypertension and Pulmonary Embolism

  2013cites this paper
• Estudio de biomarcadores de daño cardiopulmonar en la dirofilariosis canina por Dirofilaria immitis

  2013cites this paper
• [Prognostic value of troponin in patients with acute heart failure attended in Spanish Emergency Departments: TROPICA study (TROPonin in acute heart failure)].

  2013cites this paper
• ESTUDIO DE BIOMARCADORES DE DAÑO CARDIOPULMONAR EN LA DIROFILARIOSIS CANINA POR DIROFILARIA IMMITIS PROGRAMA DE DOCTORADO EN CLÍNICA

  2013cites this paper
• Heart failure.

  2013cites this paper
• Novel Cardiac Biomarkers and Application to Heart Failure

  2013cites this paper
• [Prognostic value of troponin in patients with acute heart failure attended in Spanish Emergency Departments: TROPICA study (TROPonin in acute heart failure)].

  2013cites this paper
• Nanoengineering gold particle composite fibers for cardiac tissue engineering.

  2013cites this paper
• Elective percutaneous coronary intervention: the relationship between preprocedural blood glucose levels and periprocedural myocardial injury.

  2013cites this paper
• Biological Drugs: Classic Adverse Effects and New Clinical Evidences

  2012cites this paper
• Today’s and tomorrow’s imaging and circulating biomarkers for pulmonary arterial hypertension

  2012cites this paper
• ACCF 2012 expert consensus document on practical clinical considerations in the interpretation of troponin elevations: a report of the American College of Cardiology Foundation task force on Clinical Expert Consensus Documents.

  2012cites this paper
• Where genome meets phenome: rationale for integrating genetic and protein biomarkers in the diagnosis and management of dilated cardiomyopathy and heart failure.

  2012cites this paper
• Expert Consensus Document on Practical Clinical Considerations in the Interpretation of Troponin Elevations

  2012cites this paper
• Acute decompensated heart failure - treatments and challenges - .

  2012cites this paper
• Troponin I release after intravenous treatment with high furosemide doses plus hypertonic saline solution in decompensated heart failure trial (Tra-HSS-Fur).

  2012cites this paper
• Biomarkers in heart failure

  2012cites this paper
• Trends in inflammatory biomarkers during atrial fibrillation ablation across different catheter ablation strategies.

  2012cites this paper
• Evaluation eines ultrasensitiven Troponin-I Assays als Screening-Test und zur Unterscheidung verschiedener Schweregrade der felinen hypertrophen Kardiomyopathie

  2012cites this paper
• Dual signal amplification for bioassays using ion release from nanolabels and ion-activated enzyme kinetics.

  2012cites this paper
• Acute Decompensated Heart Failure

  2012cites this paper
• Biomarqueurs pronostiques et cibles thérapeutiques du remodelage ventriculaire post infarctus du myocarde

  2011cites this paper
• Cardiac troponin I concentrations in ponies challenged with equine influenza virus.

  2011cites this paper
• Sensitive troponin assays

  2011cites this paper
• Chapter 37 – The Use of Biomarkers in the Evaluation of Heart Failure

  2011cites this paper
• Functionalized SnO₂ nanobelt field-effect transistor sensors for label-free detection of cardiac troponin.

  2011cites this paper
• Coronary Microcirculation Remodelling in Dilated Cardiomyopathy: Another Brick in the Wall

  2011cites this paper
• Cardiac Troponin I C onc entrations i n P onies C hallenged w ith E quine Influenza Virus

  2011cites this paper
• Association of troponin T, detected with highly sensitive assay, and outcomes in infective endocarditis.

  2011cites this paper
• Biomarkers in advanced heart failure: diagnostic and therapeutic insights.

  2011cites this paper
• Use of biomarkers in evaluation of patients with heart failure.

  2010cites this paper
• Diagnostic d’une insuffisance cardiaque aiguë aux urgences : intérêt d’une approche multimarqueur

  2010cites this paper
• Cardiac troponins and autoimmunity: their role in the pathogenesis of myocarditis and of heart failure.

  2010cites this paper
• Prevalence, Mechanisms, and Clinical Implications

  2010cites this paper
• Multimarker strategy for the prediction of 31 days cardiac death in patients with acutely decompensated chronic heart failure.

  2010cites this paper
• Sensitive Troponin Assays: Diagnostic and Prognostic Use in Cardiology

  2010cites this paper
• Elevated troponin T on discharge predicts poor outcome of decompensated heart failure

  2010cites this paper